Bio-Rad HIV test recall
This article was originally published in The Gray Sheet
Single lot of microwell plates performing outside expected ranges for the Genetic Systems HIV-1/HIV-2 peptide EIA qualified enzyme immunoassays test kits spawns recall, CBER announces Oct. 3. Detecting antibodies in human serum and plasma, the tests screen blood and blood products intended for transfusion or further manufacture into plasma products. Consignees are asked to contact the manufacturer to arrange for product return...
You may also be interested in...
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.